{
    "code": "02023298",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023298",
    "time": "2021-07-16 03:50:21",
    "許可證字號": "衛署藥輸字第023298號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/10\/15",
    "發證日期": "90\/10\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202329806",
    "中文品名": "健擇注射劑",
    "英文品名": "GEMZAR",
    "適應症": "非小細胞肺癌、胰臟癌、膀胱癌。GEMCITABINE與PACLITAXEL併用，可使用於曾經使用過ANTHRACYCLINE之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑類藥物(PLATINUM-BASED)治療後復發且間隔至少6個月之卵巢癌，作為第二線治療。膽道癌。",
    "劑型": "243凍晶注射劑",
    "包裝": "200公絲,1公克小瓶裝 各100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "GEMCITABINE HYDROCHLORIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "1411301100  台灣禮來股份有限公司",
    "申請商地址": "台北市復興北路３６５號１１樓",
    "主製造廠": [
        {
            "製造廠名稱": "FGR0032000  VIANEX S.A. (PLANT C)",
            "製造廠廠址": "16TH KM MARATHONOS AVENUE,15351 PALLINI ATTIKIS, GREECE",
            "製造廠公司地址": "",
            "製造廠國別": "GREECE",
            "製程": "成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FFR0118000  LILLY FRANCE",
            "製造廠廠址": "2 RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCE",
            "製造廠公司地址": "13 RUE PAGES, 92158 SURESNES, FRANCE",
            "製造廠國別": "FRANCE",
            "製程": "包裝"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "228.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "1140.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "10-Gemzar-vial (Vianex)-107-04-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023298&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "GEMZAR-Final Truth-GEM-0007-USPI-20190514+Bladder Cancer+BTC (by TFDA)_9Jul2020 v1 Clean-109-09-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023298&Seq=087&Type=9"
        },
        {
            "title": "12-Gemzar-carton and vial (Vianex)-107-04-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023298&Seq=001&Type=8"
        }
    ]
}